The survival rate of acute myeloid leukemia (AML) varies significantly depending on the age and overall health of the patient, as well as the type and stage of the disease. According to the American Cancer Society, the five-year relative survival rate for all people diagnosed with AML is 24%. That means that 24% of people with AML are expected to still be alive five years after diagnosis.
For those under the age of 60, the five-year relative survival rate is 31%. That means that 31% of those under the age of 60 with AML are expected to still be alive five years after diagnosis. Those between the ages of 60 and 69 have a five-year relative survival rate of 19%. Those over the age of 70 have the lowest five-year relative survival rate of 16%.
Additionally, the type and stage of AML can affect the survival rate. People diagnosed with AML in its early stages have a significantly higher survival rate than those diagnosed at a later stage. For those withAML in its early stages, the five-year relative survival rate can range from 40% to 60%.
Finally, overall health and treatment can also affect the survival rate. People who are in good health and receive timely and appropriate treatment have a higher chance of survival than those who are in poor health or do not receive treatment.
In conclusion, the survival rate for acute myeloid leukemia (AML) varies greatly depending on the age, overall health, type, and stage of the disease, as well as the quality of treatment received.